White 2015
White 2015
White 2015
Endovascular treatment of It is estimated that the screening programme will prevent 1900
deaths per year.
Figure 4 Angiography of an aortic stent-graft. (a) Intraoperative image, during deployment of the left limb, showing aneurysm sac (blue arrow) and lumbar
arteries (white arrows). (b) Postoperative image (completion angiogram) showing supra-renal bare stent (green arrow), renal arteries (red arrows),
branches of the superior mesenteric artery (blue bracket) and stent-graft in the aorta and common iliac arteries (white arrow).
Newer developments
Fenestrated stent-grafts
The low 30-day mortality and morbidity associated with EVAR
has encouraged surgeons to treat many patients with aneurysmal
disease who would otherwise be very high risk for an open
procedure. Juxta-renal or peri-renal aneurysms lack the
anatomical 15 mm neck required for a robust proximal seal. To
overcome this limitation, stent-grafts have been developed that
take advantage of any normal calibre aorta above the renal ostia.
A 15 mm sealing zone can be created by using a stent-graft that
has fenestrations or windows which land at the origins of the
renal arteries and the major mesenteric vessels (Figure 5). Pre-
cise landing of the stent-graft plus stenting of the renal and
mesenteric arteries to keep the stent-graft in place, will ensure
normal blood flow to the viscera and secure a proximal seal in
patients with juxta-renal aneurysms.
Branched grafts
Branched endografts (Figure 6) are used to repair type IV aneu-
rysms (i.e. where the aorta is aneurysmal from the level of the
diaphragm to its bifurcation). The proximal landing zone is
usually in a normal calibre segment of the thoracic aorta, and the
distal landing zone may be in the distal aorta or the iliac arteries.
In these complex stent-grafts, the branches are manufactured to
flare out at an angle that facilitates endovascular placement of a Figure 6 Branched stent-graft showing branches for the renal, superior
bridging stent between the main-body of the stent-graft and the mesenteric and coeliac arteries. Reproduced by kind permission from
origin of the corresponding visceral artery. Cook Medical.
stent-grafts be limited to the major specialist arterial centres for Royal College of Surgeons of England and the Vascular Society of Great
appropriately selected patients. Britain and Ireland (VSGBI) http://www.vsqip.org.uk/wp/wp-content/
uploads/2013/07/NVR-2013-Report-on-Surgical-Outcomes-Consultant-
Summary Level-Statistics.pdf. Last accessed on 18/01/2015.
Endovascular treatment of abdominal aortic aneurysm repre- 3 Arnaoutoglou E, Kouvelos G, Milionis H, et al. Post-implantation syn-
sents a paradigm shift in the management of aneurysmal disease. drome following endovascular abdominal aortic aneurysm repair;
The number of patients treated with stent-graft devices has preliminary data. Interactive Cardiovasc Thorac Surg 2010; 12:
increased significantly since the first stent-graft was inserted in 609e14.
the UK in 1991. The high degree of expertise required to deter- 4 The EVAR Trial Participants. Endovascular aneurysm repair versus open
mine which patients are suitable for EVAR and how the subse- repair in patients with abdominal aortic aneurysm (EVAR trial 1):
quent interventions should be managed has also resulted in the randomised controlled trial. Lancet 2005; 365: 2179e86.
boundaries being pushed to treat patients with more complex 5 Prinssen M, Verhoeven EL, Buth J, et al. Dutch Randomised Endovas-
aneurysmal disease. A cular Aneurysm Management (DREAM) Trial Group. A randomised trial
comparing conventional and endovascular repair of abdominal aortic
aneurysms. N Engl J Med 2004 Oct 14; 351: 1607e18.
REFERENCES
6 Lederle FA, Freischlag JA, Kyriakides TC, et al. Outcomes following
1 http://aaa.screening.nhs.uk. Last accessed on 18/01/2015.
endovascular vs open repair of abdominal aortic aneurysm. A rando-
2 National Vascular Registry Report on surgical outcomes. Consultant-
mised trial. JAMA 2009; 302: 1535e42.
level statistics. Report prepared by the Clinical Effectiveness Unit, The